BUSINESS
Lundbeck Japan Plans to Double Workforce by 2028 as It Eyes 3 Drug Approvals
Lundbeck Japan is poised for a major scale-up, with plans to roughly double its headcount from about 100 to around 200 employees by the end of 2028. President Rune Ejler Andersen says that the expansion is designed to support the…
To read the full story
Related Article
- Lundbeck Files Anti-CGRP Antibody Eptinezumab in Japan
November 18, 2025
- As Trintellix Debut Nears, Lundbeck Japan Morphing into Full-Fledged Commercial Company
November 7, 2019
BUSINESS
- China First to Approve Takeda’s Oveporexton for Narcolepsy
July 24, 2026
- FRONTEO Expects First US User of KIBIT AI Engine This Year: CEO
July 24, 2026
- Torii to Transfer Locoid MA in Japan to Cheplapharm
July 24, 2026
- Japan Vaccine Market Seen Flat in FY2026; Efluelda Delay Clouds Outlook
July 24, 2026
- Nipro Recalls Febuxostat after Finding Expired API Use at Another Plant
July 23, 2026
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…





